Bengaluru, India

Ashok Mithun

This inventor holds 1 USPTO granted patent. Top assignee: Cipla Limited. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ashok Mithun. Retrieved from https://idiyas.com/inventor/ashok-mithun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ashok Mithun: Innovator in Pharmaceutical Chemistry

Introduction

Ashok Mithun is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel drug formulations. His work focuses on improving therapeutic treatments through innovative approaches.

Latest Patents

Ashok Mithun holds a patent for "Polymorphs of Acalabrutinib," a Bruton's tyrosine kinase inhibitor. This invention discloses novel crystalline polymorphic forms of Acalabrutinib, along with methods of preparation, pharmaceutical compositions, and therapeutic treatment methods involving these polymorphic forms. This advancement has the potential to enhance the efficacy and safety of treatments for various conditions.

Career Highlights

Mithun is currently employed at Cipla Limited, a leading global pharmaceutical company. His role involves research and development, where he applies his expertise to create innovative solutions in drug formulation. His contributions have been instrumental in advancing the company's portfolio of therapeutic options.

Collaborations

Throughout his career, Ashok has collaborated with talented professionals, including Geena Malhotra and Venkata Srinivas Pullela. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking pharmaceutical innovations.

Conclusion

Ashok Mithun's work exemplifies the impact of innovation in the pharmaceutical industry. His patent on Acalabrutinib polymorphs showcases his commitment to improving patient outcomes through scientific advancement. His contributions continue to shape the future of drug development and therapeutic treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…